Evidence map›Paper›PMID 38654061›Full record

ArticleScientific reports2024

Biodiversity of carbapenem-resistant bacteria in clinical samples from the Southwest Amazon region (Rondônia/Brazil).

Levy Assis Dos Santos, Rodrigo Cayô, Tiago Barcelos Valiatti, Ana Cristina Gales, Larissa Fatarelli Bento de Araújo, Fernando Marques Rodrigues, Tatiane Silva de Carvalho, Marcos André Braz Vaz, Marcela Campanharo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Finding the MissingAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Levy Assis Dos SantosFederal University of Rondônia Foundation (UNIR), Postgraduate Program in Conservation and Use of Natural Resources (PPGReN), Porto Velho, RO, Brazil. biolevyassis@hotmail.com.
Rodrigo CayôLaboratory ALERTA, Department of Medicine, Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.
Tiago Barcelos ValiattiLaboratory ALERTA, Department of Medicine, Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.
Ana Cristina GalesLaboratory ALERTA, Department of Medicine, Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.
Larissa Fatarelli Bento de AraújoFederal University of Rondônia Foundation (UNIR), Postgraduate Program in Conservation and Use of Natural Resources (PPGReN), Porto Velho, RO, Brazil.
Fernando Marques RodriguesCentral Public Health Laboratory of Rondônia (LACEN/RO), Medical Biology Center, Porto Velho, RO, Brazil.
Tatiane Silva de CarvalhoCentral Public Health Laboratory of Rondônia (LACEN/RO), Medical Biology Center, Porto Velho, RO, Brazil.
Marcos André Braz VazDepartment of Informatics and Statistics, Federal University of Santa Catarina (UFSC), Florianópolis, SC, Brazil.
Marcela CampanharoFederal University of Rondônia Foundation (UNIR), Postgraduate Program in Conservation and Use of Natural Resources (PPGReN), Porto Velho, RO, Brazil.
Universidade Federal de São Paulo · BRUniversidade Federal de Rondônia · BRUniversidade Federal de Santa Catarina · BRUniversidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil is recognized for its biodiversity and the genetic variability of its organisms. This genetic variability becomes even more valuable when it is properly documented and accessible. Understanding bacterial diversity through molecular characterization is necessary as it can improve patient treatment, reduce the length of hospital stays and the selection of resistant bacteria, and generate data for health and epidemiological surveillance. In this sense, in this study, we aimed to understand the biodiversity and molecular epidemiology of carbapenem-resistant bacteria in clinical samples recovered in the state of Rondônia, located in the Southwest Amazon region. Retrospective data from the Central Public Health Laboratories (LACEN/RO) between 2018 and 2021 were analysed using the Laboratory Environment Manager Platform (GAL). Seventy-two species with carbapenem resistance profiles were identified, of which 25 species carried at least one gene encoding carbapenemases of classes A (bla

Indexed as

beta-LactamasesBiodiversityCarbapenemsAcinetobacter baumanniiAnti-Bacterial AgentsBacteriaBacterial ProteinsBrazilDrug Resistance, BacterialHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaRetrospective StudiesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAntimicrobial resistanceCarbapenemasesMulti-drug resistant bacteriaPublic healthSurveillance epidemiological

Identifiers

PMID38654061
PMCPMC11039742
OpenAlexW4395027118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.